|
|
|
|
|
Tuesday, 04 April 2006 09:20 | BNN: British Nursing News Online · www.bnn-online.co.uk
|
|
Details of a new partnership involving Scotland's universities, NHS Scotland, Scottish Enterprise and an American pharmaceutical firm Wyeth Pharmaceuticals was announced in New York by First Minister Jack McConnell and in Glasgow by health minister Andy Kerr.
The £50 million deal sets up the world's first 'Translational Medicine Research Collaboration'. It is intended to provide the impetus for Scotland to lead the world in medical research and bring lifesaving new drugs to patients more quickly.
After a meeting with Wyeth, First Minister Jack McConnell said: "This new partnership is an international first. It is great for Scotland and the Scottish economy and will bring health benefits not just for Scots, but for patients all over the world.
"Scotland has a world class reputation in life sciences. Our standing within the international community is high and I am delighted that one of the world's biggest pharmaceutical companies has recognised this by choosing to invest in Scotland.
"This further strengthens our position as a natural home for excellence and innovation, and will do a huge amount to raise the global profile of the pioneering work being done in our universities.
"We may be a small country, but our history shows that we have big ideas. Scots invented many of the things we take for granted and this new collaboration can secure Scotland's position as a world leader in innovation in this century too.
"This new partnership will also save lives across the world by speeding up the development of new medicines and getting them from the laboratory to the patient quicker”.
Frank Walsh, executive vice president of Wyeth Research, said: "We are delighted to be the major pharmaceutical partner in this relationship.
"Translational medicine is the key to the successful development of the next generation of innovative medicines which will truly make a difference for patients the world over”.
Health Minister Andy Kerr said: "Translational medicine research is particularly relevant to the NHS, bringing theoretical laboratory based science closer to practical applications of direct benefit to our NHS patients. It is a great example of the public and private sectors working together for mutual benefit. I am delighted that Scotland has been able to develop this pioneering approach”.
The Collaboration will comprise Aberdeen, Dundee, Edinburgh and Glasgow universities, Wyeth Pharmaceuticals, Scottish Enterprise and NHS Grampian, Greater Glasgow, Lothian and Tayside.
|
|
-
0 comments on this story
|
|
Home Top Disclaimer Site
Credits
Nursing Jobs | Just for Nurses | Nursing Agencies List | Charles Bloe Training
Nursing Portal | Nursing Events | Brutish Nursing | British Nursing Websites
Website Development and SEO Services
|
|
|